Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Fibrosis 2 Carcinoma, Hepatocellular 2 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Leiomyoma 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Pancreatic Cancer 1 Advanced Biliary Tract Carcinoma 1

Interventions

relugolix 5 Uterine Myomectomy 5 Bupivacaine 4 epigallocatechin gallate 2 Vitamin D 2 Vitamin B 6 2 Sodium Chloride 2 Observation 2 Norethindrone Acetate 2 Estradiol 2 vilaprisan 1 linzagolix 1 elagolix 1 Videotape Recording 1 Uterine Artery Embolization 1 Triamcinolone Acetonide 1 Triamcinolone 1 Therapeutics 1 Tea 1 Surveys and Questionnaires 1 Standard of Care 1 Simvastatin 1 Saline Solution 1 Robotic Surgical Procedures 1 Restraint, Physical 1 Radiofrequency Ablation 1 Naproxen 1 Morphine 1 Methadone 1 Megestrol Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyoma × Simvastatin × 1 year × Clear all

NCT03400826 2025-07-14

Effects of Simvastatin on Uterine Leiomyoma Size

Johns Hopkins University

Phase 2 Recruiting

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡